McKesson (NYSE:MCK) Launches Precision Care Initiative Transforming Oncology Treatment
McKesson (NYSE:MCK) recently introduced the Precision Care Companion, a groundbreaking initiative in oncology care, just as the company experienced a notable 18.75% price increase in the last quarter. This upward move might be influenced by their robust third-quarter earnings report, showcasing increased sales and net income, as well as the ongoing share repurchase program. These developments were in contrast to broader market trends where technology stocks suffered due to U.S. restrictions...